Replies to post #135450 on Rivulet Media Inc (fka RIVU)

[Watership]

That's waaaaaaaaaaaaaaaaaaaaaaayyyy high. Oncology, the most expensive theraputic area, doesn't even come close to that for Phase I.

The average for a therapy like Hema, a small trial group for an orphan disease, is more like $20K per patient, significantly higher than it was five years ago, but nowhere near the numbers you were quoting.

http://www.forbes.com/sites/theapothecary/2012/04/25/how-the-fda-stifles-new-cures-part-ii-90-of-clinical-trial-costs-are-incurred-in-phase-iii/